Medivation, Inc. (NASDAQ: MDVN) is a large market cap stock with a market cap of 13517.49. It is in the Biotechnology industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 36.36 and EPS of -1.08. At a stock price of 81.44 (0.02%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 0.00%, more recently this last year it has grown by 25.70%. The next year growth is going to be about 76.40% and more long-term 38.00% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been *TBA and sales growth quarter over quarter is 17.40%.
For performance, Medivation, Inc. the past week has seen a gain of 0.67%. For the last month performance for Medivation, Inc. is 1.36%. While the last quarter is 40.92% and half year, 117.81%. Finally for the year, performance is 104.47%.
The 52-week high for Medivation, Inc., is at -0.05%, and for the 52-week low it comes to a value of 208.37%. The 20-day simple moving average is 11.96% and 50.90% for the 200-day simple moving average.
Volatility for the week is at 0.11%, and for the month it is 0.23%. Medivation, Inc., has a target price of 77.79.
In terms of debt, long term debt/equity is *TBA, and for total debt/equity Medivation, Inc. has *TBA. The gross margin is *TBA, while operating margin is *TBA, the profit margin is *TBA. The current ratio is *TBA and the quick ratio is *TBA.
Insider ownership is at 1.17%, with instituitional ownership at 95.50%. Medivation, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 165.98. The shares float is 163.76, with the float short at 2.16%, with short ratio coming to 0.82.
In terms of returns, the return on assets see Medivation, Inc., get *TBA, with its returns on investment at *TBA. Return on equity is *TBA. So will the investors see the target price of 77.79, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.